ResMed Inc.
RMD
$245.73
-$13.29-5.13%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.42B | 1.34B | 1.35B | 1.29B | 1.28B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.42B | 1.34B | 1.35B | 1.29B | 1.28B |
| Cost of Revenue | 536.28M | 506.94M | 518.56M | 517.88M | 523.18M |
| Gross Profit | 886.53M | 828.64M | 829.44M | 773.85M | 758.91M |
| SG&A Expenses | 275.70M | 259.19M | 265.13M | 245.30M | 241.61M |
| Depreciation & Amortization | 19.57M | 19.78M | 21.30M | 18.34M | 18.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 922.51M | 873.24M | 891.42M | 865.47M | 864.85M |
| Operating Income | 500.30M | 462.35M | 456.57M | 426.27M | 417.24M |
| Income Before Tax | 496.15M | 446.79M | 458.05M | 417.69M | 418.32M |
| Income Tax Expenses | 103.56M | 98.26M | 78.35M | 52.65M | 73.70M |
| Earnings from Continuing Operations | 392.59M | 348.54M | 379.71M | 365.04M | 344.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 392.59M | 348.54M | 379.71M | 365.04M | 344.62M |
| EBIT | 500.30M | 462.35M | 456.57M | 426.27M | 417.24M |
| EBITDA | 543.79M | 503.64M | 513.86M | 463.68M | 457.28M |
| EPS Basic | 2.69 | 2.38 | 2.59 | 2.49 | 2.35 |
| Normalized Basic EPS | 2.16 | 2.00 | 1.97 | 1.80 | 1.79 |
| EPS Diluted | 2.68 | 2.37 | 2.58 | 2.48 | 2.34 |
| Normalized Diluted EPS | 2.15 | 1.99 | 1.97 | 1.80 | 1.78 |
| Average Basic Shares Outstanding | 145.84M | 146.18M | 146.47M | 146.72M | 146.81M |
| Average Diluted Shares Outstanding | 146.37M | 146.90M | 147.04M | 147.22M | 147.48M |
| Dividend Per Share | 0.60 | 0.60 | 0.53 | 0.53 | 0.53 |
| Payout Ratio | 22.31% | 25.18% | 20.43% | 21.29% | 22.54% |